Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-01 22:39:29 - browse：11135

Jakub Porzycki/NurPhoto via AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.

The need-to-know this morning

Apellis Pharmaceuticals said a European advisory committee is expected to recommend against the approval of Syfovre, its eye drug for a common form of blindness. The company plans to appeal the negative ruling.
Sage Therapeutics and Biogen announced the commercial launch of Zurzuvae, an oral treatment for women with postpartum depression.
Merck and Moderna reported three-year follow-up data on their mRNA-based immunotherapy for advanced melanoma. Phase 3 studies are underway.
The FDA accepted Amgen’s marketing application for tarlatamab, a bispecific antibody to treat advanced small cell lung cancer. The approval decision date is June 12, 2024.

Is it time to worry about Moderna?

Yesterday’s news that Pfizer is expecting to sell far fewer Covid-19 vaccines than Wall Street expected sent shares of Moderna down as much as 6% on fears that the company could be in for a painful revision of its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Time to name cancers by genetics, not organ of origin, expert says

focus

WSS

Ukraine and a new approach to mental health in war

ARCH Venture Partners is raising $3 billion for a life sciences fund

How Vertex's cystic fibrosis drug is changing patients' lives

What we need to know about Arena Bioworks

FDA panel to weigh approval of NurOwn, controversial ALS drug

Novo Nordisk to expand supply of Wegovy for U.S. patients

leisure time

Wikipedia

The need-to-know this morning

Is it time to worry about Moderna?

explore

Walensky prepares to leave CDC — and Congress — behind

General Catalyst, Summa Health deal will turn on physician buy

23andMe had bad news about my health. I wish a person had delivered it

How AI helped researchers track recovery from depression

ChatGPT in medicine: STAT answers readers' burning questions

Covid misinformation case heads to Supreme Court

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What we need to know about Arena Bioworks

Duchenne breakthrough therapy leaves behind pioneering families

Changes to biosimilar regulatory framework must prioritize patients

knowledge

What Congress can do to address the rural doctor shortage

Changes to biosimilar regulatory framework must prioritize patients

Quicker fix for pulse oximeters urged during FDA public meeting

CommonSpirit Health keeps growing, even as it loses money

What we need to know about Arena Bioworks

CDC's new outbreak response network to include Northeastern

focus

hotspot

leisure time

knowledge